(Q47831371)

6 February 2018

title

Immunogenicity of Plasmodium falciparum circumsporozoite protein multiple antigen peptide vaccine formulated with different adjuvants. (English)

1 reference

6 February 2018

main subject

Plasmodium falciparum

1 reference

15

Hoffman SL

1 reference

6 February 2018

Le TP

1

1 reference

6 February 2018

Church LW

2

1 reference

6 February 2018

Corradin G

3

1 reference

6 February 2018

Hunter RL

4

1 reference

6 February 2018

Charoenvit Y

5

1 reference

6 February 2018

Wang R

6

1 reference

6 February 2018

de la Vega P

7

1 reference

6 February 2018

Sacci J

8

1 reference

6 February 2018

Ballou WR

9

1 reference

6 February 2018

Kolodny N

10

1 reference

6 February 2018

Kitov S

11

1 reference

6 February 2018

Glenn GM

12

1 reference

6 February 2018

Richards RL

13

1 reference

6 February 2018

Alving CR

14

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 January 1998

1 reference

6 February 2018

published in

Vaccine

1 reference

6 February 2018

volume

16

1 reference

6 February 2018

issue

2-3

1 reference

6 February 2018

page(s)

305-312

1 reference

6 February 2018

Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900165-5

7 January 2021

Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900165-5

7 January 2021

Synthetic peptide vaccine confers protection against murine malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900165-5

7 January 2021

Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900165-5

7 January 2021

Inability of Malaria Vaccine to Induce Antibodies to a Protective Epitope Within Its Sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900165-5

7 January 2021

Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900165-5

7 January 2021

Safety, immunogenicity, and efficacy of a malaria sporozoite vaccine administered with monophosphoryl lipid A, cell wall skeleton of mycobacteria, and squalane as adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900165-5

7 January 2021

Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900165-5

7 January 2021

Immunogenicity of multiple antigen peptides (MAP) containing T and B cell epitopes of the repeat region of theP. falciparum circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900165-5

7 January 2021

Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900165-5

7 January 2021

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900165-5

7 January 2021

Induction of a cytotoxic T cell response by co-injection of a T helper peptide and a cytotoxic T lymphocyte peptide in incomplete Freund's adjuvant (IFA): further enhancement by pre-injection of IFA alone

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900165-5

7 January 2021

Liposomes as carriers for vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900165-5

7 January 2021

Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900165-5

7 January 2021

Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900165-5

7 January 2021

Induction of protective cytotoxic T cells to murine cytomegalovirus by using a nonapeptide and a human-compatible adjuvant (Montanide ISA 720).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900165-5

7 January 2021

Copolymer adjuvants in malaria vaccine development.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900165-5

7 January 2021

A comparison of commercially available adjuvants for use in research

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900165-5

7 January 2021

Use of adjuvant containing mycobacterial cell-wall skeleton, monophosphoryl lipid A, and squalane in malaria circumsporozoite protein vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900165-5

7 January 2021

Liposomes as Carriers of Peptide Antigens: Induction of Antibodies and Cytotoxic T Lymphocytes to Conjugated and Unconjugated Peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900165-5

7 January 2021

10.1016/S0264-410X(97)00165-5

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018